Indivior stock highlights USD 8.13 dividend plan

Published on 10/03/2026 at 23:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Indivior stock closed at USD 35.71 on October 2, 2026, up 0.93 percent on Nasdaq. Q2 revenue reached USD 343.0 million as the merger condition shapes the payout.

Moderne Pharma-Produktionsanlage mit Glasfassade und Industrieanlagen im Tageslicht — Indivior PLC mit ISIN GB00BYZ0C031 betreibt moderne Pharma-Produktionsanlage für innovative Suchtmedizin-Präparate weltweit an Patienten, Illustration mit AI erstellt.

Indivior (ISIN US45579U1097) closed at USD 35.71 on Nasdaq on October 2, 2026, up 0.93 percent from the prior close of USD 35.38. The central corporate event is a USD 8.13 special dividend declared on September 17, 2026, with payment conditional on the proposed Supernus merger, according to Indivior.

Dividend depends on merger closing

Indivior set October 30, 2026, as the record date for eligible holders. The company expects the merger with Supernus to close on or about November 2, 2026, with the dividend payment anticipated on or about November 6, 2026, subject to the transaction closing.

The filing also identifies a clear counter-factor: the payout depends on shareholder approvals and other closing conditions. The SEC filing dated September 16, 2026, says the special dividend is contingent on the merger and that the transaction may involve additional indebtedness.

Revenue gives the stock operating support

Indivior reported USD 343.0 million of revenue for Q2 2026, according to MarketBeat. That quarterly figure gives investors an operating reference alongside the merger-related distribution, rather than leaving the stock story dependent on the dividend alone.

MarketBeat also reported six buy ratings and one hold rating, producing a Moderate Buy consensus and an average 12-month price target of USD 45.1667. That target is 26.5 percent above the October 2 closing price of USD 35.71, a quantified gap that highlights the difference between the market quotation and published analyst expectations.

Stock remains below its yearly high

The USD 35.71 closing price sits within a 52-week range of USD 22.56 to USD 42.81. The USD 4.5 billion market capitalization and 1,649,816-share session volume give the payout plan a substantial listed-company backdrop, while the 19.9 percent distance from the yearly high keeps the chart context visible.

For investors, the key checkpoint is the sequence of October 30, November 2 and November 6, 2026. The first date determines eligibility, the second is the expected merger date, and the third is the anticipated payment date if the transaction closes.